Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy

BACKGROUND: Nausea and vomiting of pregnancy (NVP) affects up to 80% of expecting mothers. In April 2013 the FDA approved the delayed-release combination of doxylamine succinate and pyridoxine hydrochloride (Diclegis®) for NVP, based in part, on the results of a phase III randomized trial demonstrat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Pregnancy Childbirth
Asıl Yazarlar: Koren, Gideon, Clark, Shannon, Hankins, Gary D. V., Caritis, Steve N., Umans, Jason G., Miodovnik, Menachem, Mattison, Donald R., Matok, Ilan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5122025/
https://ncbi.nlm.nih.gov/pubmed/27881103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12884-016-1172-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller